Product Program year 2024 Source: CMS Open Payments

Tiopronin

Drug Urology

NDC 0093-7909-01

Open in the dashboard

General payments

$3,228

150 payments

Research payments

$0

0 payments

Through program year 2024, $3,228 in general payments and $0 in research payments were reported against Tiopronin (Urology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $3,228 150

Breakdown

Who paid General payments · program year 2024
  1. Cycle Pharmaceuticals Inc $3,228 150 payments
Top recipients General payments · program year 2024
  1. Steven Yablon Nephrology · West Nyack, NY $78 2% · 1 payment
  2. Ronald Rubenstein Urology · Royal Oak, MI $67 2% · 1 payment
  3. Zalman Suldan Nephrology · Teaneck, NJ $57 2% · 1 payment
  4. Arthur Kozin Nephrology · West Nyack, NY $49 2% · 1 payment
  5. Kara Parker Nurse Practitioner, Women's Health · Richmond, VA $48 1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Urology $1,203 38% · 55 practitioners
  2. Nephrology Internal Medicine $950 30% · 42 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $190 6% · 11 practitioners
  4. Physician Assistant $146 5% · 6 practitioners
  5. Nurse Practitioner $101 3% · 5 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Florida $520 16% · 24 recipients
  2. Virginia $502 16% · 20 recipients
  3. Alabama $322 10% · 20 recipients
  4. New York $313 10% · 9 recipients
  5. New Jersey $310 10% · 11 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

150 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record